A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Clinical trial NCT05263999 · TERMINATED

Trial details

NCT number: NCT05263999
Sponsor: Equillium
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Graft Versus Host Disease GVHD Acute-graft-versus-host Disease Acute GVHD aGVHD

Start date: 2022-04-29
Primary completion: 2025-04-22
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.